tiprankstipranks
Ionis Pharmaceuticals (IONS)
NASDAQ:IONS
US Market
IONS
Ionis Pharmaceuticals
RESEARCH TOOLSreports
Want to see IONS full AI Analyst Report?

Ionis Pharmaceuticals (IONS) Stock News & Sentiment

1,495 Followers
Ionis Pharmaceuticals’ Earnings Call Flags Growth and Risks
Premium
Company Announcements
Ionis Pharmaceuticals’ Earnings Call Flags Growth and Risks
5d ago
IONS
Analyst Reiterates Buy Rating on Ionis Pharmaceuticals, Maintains $105 Price Target on Strong Q1 and Upgraded Olezarsen Outlook
Premium
Ratings
Analyst Reiterates Buy Rating on Ionis Pharmaceuticals, Maintains $105 Price Target on Strong Q1 and Upgraded Olezarsen Outlook
5d ago
IONS
Ionis Pharmaceuticals Inc. (IONS) Q1 Earnings Cheat Sheet
Premium
Pre-Earnings
Ionis Pharmaceuticals Inc. (IONS) Q1 Earnings Cheat Sheet
8d ago
IONS
Ionis Pharmaceuticals: Advancing Neurology Franchise Underscored by Zilganersen’s Strong Phase III Data in Alexander Disease
Premium
Ratings
Ionis Pharmaceuticals: Advancing Neurology Franchise Underscored by Zilganersen’s Strong Phase III Data in Alexander Disease
13d ago
IONS
Ionis Expands Its Rare Epilepsy Pipeline With New ASCEND Trial in Dravet Syndrome
Premium
Company Announcements
Ionis Expands Its Rare Epilepsy Pipeline With New ASCEND Trial in Dravet Syndrome
14d ago
IONS
Ionis Highlights Positive Zilganersen Data in Alexander Disease
Premium
Company Announcements
Ionis Highlights Positive Zilganersen Data in Alexander Disease
14d ago
8K
IONS
Ionis Extends Donidalorsen Into Children: What the New HAE Trial Means for Investors
Premium
Company Announcements
Ionis Extends Donidalorsen Into Children: What the New HAE Trial Means for Investors
28d ago
IONS
More IONS News >

IONS News on the Web

Insider Sell: B Parshall Sells 5,000 Shares of Ionis Pharmaceuticals Inc (IONS)
GuruFocus News
Neutral
Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), Eli Lilly & Co (LLY) and Ionis Pharmaceuticals (IONS)
TipRanks News
Neutral
Nike downgraded, IBM initiated: Wall Street’s top analyst calls
TipRanks News
Bullish
Ionis Pharmaceuticals resumed with an Outperform at Raymond James
TipRanks News
Neutral
CNBC Cures: A father and a doctor on how raising a child with Angelman syndrome changed him
CNBC
Neutral
Ionis Pharmaceuticals price target raised to $111 from $100 at BofA
TipRanks News
Bullish
Analysts Are Bullish on These Healthcare Stocks: EDAP TMS (EDAP), Ionis Pharmaceuticals (IONS)
TipRanks News
Neutral
Ionis Extends Donidalorsen Into Children: What the New HAE Trial Means for Investors
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
IONS
Sector Average
Media Buzz
This Week2 articles
Weekly Average7.25 articles
News Sentiment
This Week50%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is IONS’s Media Buzz Sentiment?
2 articles about IONS were published this week. In an average week, 7.25 articles are published.
    What is IONS’s weekly average amount of articles?
    In an average week, 7.25 articles about IONS are published.
      What is IONS’s News Sentiment?
      50% of articles about IONS were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week